Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

Find the latest Drugs in Development and Pipeline Prospector News of BioAdaptives.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
BioAdaptives
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
2620 Regatta Drive Suite 102 Las Vegas NV 89128
Telephone
Telephone
(877) 252 – 8282
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

PluriPain-PMS, an advanced, all natural anti-inflammatory and mood-enhancing Women’s Health formula to combat specific symptoms associated with the menstrual cycle.


Lead Product(s): Vitamin D,Calcium,Potassium

Therapeutic Area: Immunology Product Name: PluriPain-PMS

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable October 05, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

The agreement aims to market a patented product for Eye Health due to Myopia and Presbyopia. This Patent is a liposome and sustained release polymeric micelles preparation that improves the solubility of lutein.


Lead Product(s): Lutein,Astaxanthin

Therapeutic Area: Ophthalmology Product Name: Undisclosed

Highest Development Status: PreclinicalProduct Type: Small molecule

Partner/Sponsor/Collaborator: LY Research Corporation

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement March 30, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

PluriPain, is a safe, all-natural supplement formula to manage your aching joints, sore back and other pains.


Lead Product(s): Phycocyanin,Methylsulphonylmethane,Boswellia Serata

Therapeutic Area: Neurology Product Name: PluriPain

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable July 14, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Dr. Koran’s of Stanford Medical Center will study BioAdaptives' natural supplement formulation, PluriPain®, for its pain-relieving, anti-inflammatory and antioxidant effects. BioAdaptives’ participation is limited to providing PluriPain® for Dr. Koran’s research.


Lead Product(s): Phycocyanin,Methylsulphonylmethane,Boswellia Serata

Therapeutic Area: Neurology Product Name: PluriPain

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Stanford Medical Center

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration August 26, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY